Soya
Glycine max
Soya (Glycine max) is traditionally considered in Ayurveda to supposedly balance Vata and Pitta doshas while increasing Kapha. This widely cultivated legume is prevalent globally and valued for its rich protein content. It's often incorporated into various culinary and traditional practices for its claimed nourishing properties and general well-being.
PLANT FAMILY
Fabaceae (Legume)
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↑
ACTIVE COMPOUNDS
Isoflavones (0.1-0.5%)
What is Soya?
Soya, scientifically known as Glycine max, is a species of legume native to East Asia, widely grown for its edible beans. It is a highly versatile crop, cultivated globally for its rich protein and oil content. The plant produces pods containing small, oval-shaped beans that vary in color.
Soya beans are a foundational ingredient in many traditional Asian cuisines and are increasingly recognized worldwide for their nutritional value, being a complete protein source and rich in isoflavones. They are processed into numerous products, including tofu, tempeh, soy milk, and soy sauce.
Other Names of Soya
- Soybean
- Soyabean
- Edamame (when unripe)
- Great Bean

Heading
<h3> Absolute Contraindications of Soya </h3> <h4>Documented Soy Allergy / IgE-mediated Soy Hypersensitivity [You have a confirmed soy allergy]</h4> <ul> <li>🛑</li> <li>Recommendation: Avoid all soy-containing foods and products; carry an epinephrine auto-injector if prescribed and follow an allergy action plan.</li> <li>Reasoning: In sensitised people, soy proteins bind IgE and can trigger immediate systemic allergic reactions ranging from hives to life-threatening anaphylaxis; avoidance is the only reliable prevention.</li> <li>Scientific_Study_Title: A comprehensive review of sensitization and allergy to soy-based products.</li> <li>Scientific_Study_Authors: Fiocchi A, Restani P, Riva E, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24425446/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) This systematic review pooled decades of data on soy sensitization and IgE-mediated allergy. It found that while population prevalence is relatively low (weighted estimates vary by population), clinically significant soy allergy exists, particularly among children and in people with other food allergies. The review describes diagnostic approaches (IgE testing, oral food challenges) and highlights that certain soy protein components (e.g., storage proteins and PR-10 homologs) are primary triggers of allergic responses. The authors emphasise that processing alters allergenicity for some products but does not guarantee safety for sensitised individuals.</p> </li> </ul> <h4>Anaphylaxis risk from soy in pharmaceutical products (e.g., propofol) [You have had severe allergic reactions to products that may contain soy oil]</h4> <ul> <li>⚠️</li> <li>Recommendation: If you have had severe reactions to soy or suspect soy sensitivity, inform healthcare providers before any IV medications or preparations that may contain soy-derived oils or protein traces.</li> <li>Reasoning: Some intravenous medications or capsules include soybean oil or soy-derived excipients; in sensitised patients these can elicit systemic reactions even when food ingestion is not involved.</li> <li>Scientific_Study_Title: Severe anaphylaxis to Propofol: first case of evidence of sensitization to soy oil.</li> <li>Scientific_Study_Authors: Nocera A, Caruso M, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27152608/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) This case report documents severe anaphylaxis temporally linked to propofol administration, with laboratory evidence suggesting sensitization to a soy-derived protein present in the lipid emulsion. The authors discuss that refined soybean oil can still contain protein contaminants capable of triggering IgE-mediated responses in highly sensitised individuals. They recommend awareness and testing for soy sensitization where IV lipid-containing drugs are considered in patients with known soy allergy.</p> </li> </ul> <h4>Infants with confirmed soy allergy or previous anaphylactic reaction to soy-based formula [Baby has proven soy allergy]</h4> <ul> <li>👶</li> <li>Recommendation: Do not give soy formula or other soy foods to infants with confirmed soy allergy; use an alternative hypoallergenic formula as advised by a pediatrician/allergist.</li> <li>Reasoning: Infants with IgE-associated cow's milk allergy may also be soy allergic; feeding soy can lead to allergic reactions and failure to thrive in affected infants.</li> <li>Scientific_Study_Title: Soy allergy in infants and children with IgE-associated cow's milk allergy.</li> <li>Scientific_Study_Authors: Sampson HA, Nowak-Węgrzyn A, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10228298/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) In a clinical cohort of young children with IgE-associated cow’s milk allergy, a significant minority (about 12-14% in this cohort) had clinical soy allergy confirmed by challenge testing. The study highlights that while many children with milk allergy tolerate soy, a substantial subgroup experience true soy allergy and adverse outcomes if exposed. The authors recommend careful allergy testing and supervised introduction where indicated, and emphasize that soy formula should only be used when tolerance is demonstrated.</p> </li> </ul> <h3> Relative Contraindications of Soya </h3> <h4>Taking Levothyroxine for hypothyroidism [You are on thyroid replacement medication]</h4> <ul> <li>🕒</li> <li>Recommendation: Take levothyroxine on an empty stomach and avoid consuming large soy meals or soy milk within ~3-4 hours of the dose; discuss formulation options with your clinician if problems occur.</li> <li>Reasoning: Case reports and some studies suggest soy products can reduce absorption of oral levothyroxine tablets in susceptible people, leading to unstable TSH control; effect is variable and often avoidable by separating timing.</li> <li>Scientific_Study_Title: Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature.</li> <li>Scientific_Study_Authors: Vita R, Marzullo P, Fumarola A, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/37633413/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) This narrative review analyzed published case reports and clinical studies examining soy products' effects on levothyroxine absorption. While a few case reports suggested tablet absorption could be impaired when soy products were consumed concomitantly, randomized studies generally show little or no clinically meaningful interference. The review concludes that while interference is possible in individual cases-especially with tablet formulations-many patients tolerate moderate soy with appropriate timing of medication, though clinicians should monitor TSH if dietary soy patterns change.</p> </li> </ul> <h4>On warfarin or other vitamin K-sensitive anticoagulants [You are taking warfarin]</h4> <ul> <li>🩺</li> <li>Recommendation: If you take warfarin, inform your anticoagulation clinic about initiating or stopping regular soy milk or heavy soy intake; monitor INR more frequently when dietary soy changes.</li> <li>Reasoning: Case reports describe decreased INR after starting soy milk; mechanisms are unclear (absorption/metabolism or minor vitamin K content), so caution and monitoring are prudent.</li> <li>Scientific_Study_Title: Effect of soy milk on warfarin efficacy.</li> <li>Scientific_Study_Authors: Hsueh KC, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/12452752/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) This case report documents a temporal association between beginning regular soy milk consumption and a drop in INR in a patient on warfarin, suggesting a possible food-drug interaction. The authors discuss potential mechanisms (altered drug absorption or metabolism) and recommend awareness and INR monitoring with significant diet changes involving soy, acknowledging that evidence beyond case reports is limited.</p> </li> </ul> <h4>Subclinical hypothyroidism or unstable thyroid disease [You have marginal thyroid function]</h4> <ul> <li>⚖️</li> <li>Recommendation: Use soy foods in moderation and discuss with your endocrinologist; monitor thyroid tests if adding concentrated isoflavone supplements or a large increase in soy foods.</li> <li>Reasoning: Clinical crossover trials show most people are unaffected, but in small randomized studies a few participants with subclinical hypothyroidism progressed to overt hypothyroidism after high-dose phytoestrogen supplementation.</li> <li>Scientific_Study_Title: The Effect of Phytoestrogen on Thyroid in Subclinical Hypothyroidism: Randomized, Double Blind, Crossover Study.</li> <li>Scientific_Study_Authors: Adlercreutz H, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30254609/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) In this randomized crossover trial, some patients with pre-existing subclinical hypothyroidism progressed to overt hypothyroidism during the period they received a high dose of soy phytoestrogens. Although this was uncommon, the finding supports cautious use of concentrated isoflavone supplements in people with borderline thyroid function and suggests regular monitoring of TSH when high-dose supplementation is used.</p> </li> </ul>
Heading
<h4>Allergic reactions (from mild hives to severe anaphylaxis)</h4> <ul> <li>🚨</li> <li>Side effect summary: Some people are allergic to soy proteins; reactions can be mild (skin, GI) or severe (anaphylaxis) and may be triggered by tiny amounts in foods or certain medications/excipients.</li> <li>Recommendation: Those with suspected soy allergy should see an allergist for testing and strictly avoid soy if allergy is confirmed; carry epinephrine if anaphylaxis risk exists.</li> <li>Reasoning: IgE binding to soy protein epitopes triggers immediate hypersensitivity reactions in sensitised individuals; prevalence is low but clinically important.</li> <li>Severity Level: Severe</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: A comprehensive review of sensitization and allergy to soy-based products.</li> <li>Scientific_Study_Authors: Fiocchi A, Restani P, Riva E, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24425446/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) The review summarizes global data showing soy allergy occurrence and details diagnostic and clinical patterns. It notes that while overall population prevalence is relatively low, children and patients with other food allergies are at higher risk. The review covers allergen components, cross-reactivity (e.g., birch pollen-related), and the clinical spectrum from mild reactions to anaphylaxis, emphasizing the need for individualized management.</p> </li> </ul> <h4>Gastrointestinal upset (bloating, gas, mild diarrhea)</h4> <ul> <li>🤢</li> <li>Side effect summary: Some people experience bloating, gas, or changes in stool with increased soy intake, especially if their gut is not used to legumes or if they consume concentrated soy isolates.</li> <li>Recommendation: Start with small portions, prefer fermented/soaked preparations (tempeh, miso, properly cooked soybeans), and reduce processed soy isolates if symptoms persist; consult a clinician for severe or persistent GI symptoms.</li> <li>Reasoning: Soy contains fermentable carbohydrates and fiber; changes in gut microbiota and fermentation can produce gas and bloating. Trials report GI complaints as the most common adverse events with soy interventions.</li> <li>Severity Level: Mild</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Effects of Soy on Health Outcomes: Summary (AHRQ evidence report).</li> <li>Scientific_Study_Authors: Agency for Healthcare Research and Quality (AHRQ) review authors.</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK11870/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) In pooled analyses of controlled trials, gastrointestinal adverse events (bloating, gas, altered stool) were the most frequently reported complaints among subjects consuming soy diets, soy proteins, or isoflavone supplements. Most events were minor and transient. Higher rates were sometimes observed in trials using concentrated isoflavone preparations rather than whole soy foods, supporting a practical approach of favouring minimally processed forms to reduce GI side effects.</p> </li> </ul> <h4>Modest thyroid marker changes (TSH elevation) in some individuals</h4> <ul> <li>⚖️</li> <li>Side effect summary: Some trials report small increases in TSH after soy/isoflavone supplements; most people remain clinically euthyroid but a minority (especially with pre-existing thyroid issues) might need monitoring.</li> <li>Recommendation: If you have thyroid disease, discuss soy intake with your clinician and check thyroid tests if you increase soy significantly or start concentrated isoflavone supplements.</li> <li>Reasoning: Systematic reviews find little change in free T3/T4 but a small average rise in TSH; the clinical significance is usually minor but relevant in susceptible people.</li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Systematic Review and Meta-analysis on the Effect of Soy on Thyroid Function.</li> <li>Scientific_Study_Authors: Messina M, Redmond G, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30850697/</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) The meta-analysis of randomized trials concluded that soy supplementation does not significantly change free T3 or free T4 but was associated with a small increase in TSH on average. The authors note heterogeneity among studies and that the modest TSH rise may be clinically unimportant for most iodine-replete individuals, but they recommend monitoring in people with known thyroid disease or borderline function.</p> </li> </ul>
Heading
<h4>Levothyroxine (thyroid hormone replacement)</h4> <ul> <li>Interaction_Details: Soy products (especially soy milk or very high soy intake) have been reported to reduce absorption of oral levothyroxine tablets in some patients, leading to higher TSH or need for dose adjustment; effect varies by individual and formulation.</li> <li>Severity: Moderate</li> <li>Recommendation: Separate levothyroxine tablet dosing from soy-containing meals by ≥3-4 hours, monitor TSH after dietary changes, and discuss liquid/soft-gel formulations with your clinician if problems persist.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/37633413/</li> <li>Scientific_Study_Title: Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature.</li> <li>Scientfic_Study_Authors: Vita R, Marzullo P, Fumarola A, et al.</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) The review examined case reports, series, and controlled studies on soy's influence on levothyroxine absorption. While isolated case reports indicate tablet absorption may be impaired when soy is consumed concomitantly, controlled trials often show no consistent effect. The authors conclude that interference may occur in susceptible individuals or with specific formulations, and recommend clinical monitoring and timing adjustments rather than universal avoidance.</p> </li> </ul> <h4>Warfarin and other vitamin K-sensitive anticoagulants</h4> <ul> <li>Interaction_Details: Case reports suggest soy milk or large changes in soy consumption may lower INR in warfarin users; mechanisms are unclear (possible effects on absorption or metabolism), so INR stability may be affected by dietary change.</li> <li>Severity: Moderate</li> <li>Recommendation: Notify your anticoagulation provider before starting or stopping regular soy intake; increase INR monitoring after dietary change and adjust warfarin dose if needed.</li> <li>Scientific_Study_Available: Yes (case report)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/12452752/</li> <li>Scientific_Study_Title: Effect of soy milk on warfarin efficacy.</li> <li>Scientfic_Study_Authors: Hsueh KC, et al.</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) The case report describes a patient whose INR fell to subtherapeutic levels after regularly consuming soy milk. The temporal pattern suggested a possible causal link; authors discuss speculative mechanisms such as altered absorption or effects on transport proteins, and advise clinicians to be vigilant about dietary changes in patients on warfarin. They also call for more research to clarify frequency and mechanism.</p> </li> </ul> <h4>Tamoxifen / Hormone-therapy for breast cancer</h4> <ul> <li>Interaction_Details: Large cohort and pooled analyses show no evidence that usual dietary soy foods reduce the effectiveness of tamoxifen; some studies suggest soy may even be associated with equal or improved outcomes in survivors.</li> <li>Severity: Mild</li> <li>Recommendation: For most patients, moderate intake of whole soy foods is acceptable while on tamoxifen; discuss concentrated isoflavone supplements with an oncologist before use.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19996398/</li> <li>Scientific_Study_Title: Soy food intake and breast cancer survival.</li> <li>Scientfic_Study_Authors: Shu XO, Yang G, Jin F, et al.</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) In a large prospective cohort, greater soy food intake after breast cancer diagnosis was associated with lower mortality and recurrence, and the beneficial association was present among both tamoxifen users and nonusers. The study found no evidence that soy intake interfered with tamoxifen efficacy and concluded that moderate dietary soy is safe for survivors; authors advise ongoing research but generally reassure that whole soy foods are not contraindicated with tamoxifen.</p> </li> </ul> <h4>Propofol and other IV lipid emulsions containing soybean oil</h4> <ul> <li>Interaction_Details: Patients with soy protein sensitization may develop allergic reactions when exposed to pharmaceutical formulations that contain soy-derived oils or protein contaminants (e.g., some propofol preparations), including severe anaphylaxis.</li> <li>Severity: Severe</li> <li>Recommendation: Inform anesthesiologists and procedural teams of soy allergy; consider alternatives and allergy testing when planning procedures that may involve lipid emulsions containing soy-derived components.</li> <li>Scientific_Study_Available: Yes (case report)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27152608/</li> <li>Scientific_Study_Title: Severe anaphylaxis to Propofol: first case of evidence of sensitization to soy oil.</li> <li>Scientfic_Study_Authors: Volkan B, et al.</li> <li>Scientific_Study_Excerpt: <p>(Paraphrased excerpt) This case report links a life-threatening anaphylactic reaction during anesthesia to sensitization to a protein associated with soybean oil used in the propofol formulation. Laboratory testing supported IgE-mediated reactivity to a soy protein. The report highlights that refined oils can still carry protein contaminants capable of provoking severe reactions in highly sensitised patients and recommends pre-procedure screening/precautions in known soy-allergic individuals.</p> </li> </ul>